Trimethoprim Sulfamethoxazole
Trimethoprim Sulfamethoxazole - Related Videos
04:19
Oral Combinational Antiretroviral Therapy to Treat HIV-1 Infection in a Humanized Mouse Model
0 Views •
2025
This video demonstrates an assay to evaluate the effectiveness of oral combined antiretroviral therapy (oral cART) in a human immunodeficiency virus-1 (HIV-1)-infected humanized mouse model. A combination of drugs targeting HIV-1, including nucleoside reverse transcriptase inhibitors and integrase strand transfer inhibitors, is administered along with a nutritional supplement and antibiotics. Following the consumption of this mixture by the humanized mice infected with HIV-1, the effective...
08:30
One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
0 Views •
Cited by 7 •
2012
The design of a straightforward one-day workflow scheme for bacterial pathogen diagnostics enables the rapid recognition of bloodstream infections. The inclusion of eight clinically relevant bacterial targets and their antibiotic resistance profiles offers the clinician an initial insight on the same day, which can lead to more adequate therapy.
07:56
Parabiosis in Mice: A Detailed Protocol
0 Views •
Cited by 175 •
2013
Parabiotic joining of two organisms leads to the development of a shared circulatory system. In this protocol, we describe the surgical steps to form a parabiotic connection between a wild-type mouse and a constitutive GFP-expressing mouse.
02:45
Bacterial Growth on a Microfluidic Chip to Study Antibiotic Drug Resistance
0 Views •
2025
Source: Liu, P. C., et al. Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection. J. Vis. Exp. (2016)This video demonstrates the use of a microfluidic chip to visualize and compare the growth and morphology of wild-type and trimethoprim-resistant E. coli strains under trimethoprim antibiotic stress.
09:11
Implantation of Radiotelemetry Transmitters Yielding Data on ECG, Heart Rate, Core Body Temperature and Activity in Free-moving Laboratory Mice
0 Views •
Cited by 56 •
2011
A surgical technique for implantation of commercially available telemetry transmitters used for continuous measurement of biopotential (one-lead ECG), heart rate, core body temperature and locomotor activity in freely moving mice is shown. Recommendations and protocols for post-operative care and pain relief, improving recovery, well being and survival rate are also presented.
FAQs
Blocking two consecutive steps in microbial folate production can produce greater antibacterial activity than either component alone. Sulfamethoxazole acts earlier at dihydropteroate synthase, whereas trimethoprim acts later at dihydrofolate reductase. This complementary arrangement limits the production of folate-dependent nucleic acids, helping explain why the fixed-dose combination can be therapeutically useful against susceptible organisms.
Antimicrobial resistance can reduce or eliminate the expected activity of trimethoprim sulfamethoxazole against a target organism. Consequently, the combination should be considered in relation to whether the infection is caused by a susceptible bacterium rather than selected solely because two antibacterial agents are present. Resistance therefore connects microbiologic findings with therapeutic choice and limits the situations in which the regimen is appropriate.
Therapeutic selection requires more than matching the antibacterial spectrum to an infection. Pharmacologists must also account for dosing, potential drug interactions, and adverse effects, because each factor can alter the balance between treatment benefit and patient safety. These considerations are important when deciding whether this fixed-dose combination is suitable for a particular clinical situation and how its use should be approached.
The combination may be considered for susceptible urinary tract, respiratory, or skin infections, as well as Pneumocystis jirovecii pneumonia and select opportunistic infections. Its role depends on linking the infection type with expected microbial susceptibility and the patient-safety factors relevant to therapy. Thus, the same pharmacologic product can serve different purposes across routine bacterial and opportunistic infectious settings.
Its use against Pneumocystis jirovecii pneumonia and other select opportunistic infections shows that the combination has relevance beyond common urinary, respiratory, and skin infections. This broader application illustrates how pharmacology connects a drug’s antimicrobial mechanism with the clinical setting, the organism involved, and the need to weigh dosing, interactions, adverse effects, and susceptibility when selecting treatment.
A fixed-dose design places sulfamethoxazole and trimethoprim together as one antibacterial combination, reflecting their intended complementary action on consecutive folate-production steps. Pharmacologically, this format requires the two agents to be considered as a coordinated regimen while still accounting for dosing, interactions, adverse effects, and susceptibility. It therefore illustrates how formulation and mechanism jointly influence therapeutic choice and safety.